This report is the second study conducted by Charles River Associates on the role and impact of Health Technology Assessment (HTA) worldwide. The report assesses the performance of the HTA process in 16 countries with mature or developing HTA systems according to international best practice principles.
To read the report, please click below.
Strategic implications for the 340B Rebate Model Pilot Program
These entities receive discounts on all eligible covered outpatient drugs. The program has expanded substantially over the years, with the number of covered...